Back
ACS Actividades de Construccion y Servicios SA Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
84
ACSAY
ACS Actividades de Construccion y Servicios SA
Last Price:
9.52
Seasonality Move:
8.91%
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
259.70
Seasonality Move:
31.67%
Buy
84
ACS Actividades de Construccion y Servicios SA (ACSAY)
is a Buy
Is ACS Actividades de Construccion y Servicios SA a Buy, Sell or Hold?
- The current ACS Actividades de Construccion y Servicios SA [ACSAY] share price is $9.52. The Score for ACSAY is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- ACSAY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACSAY Stock Price Chart
What is ACS Actividades de Construccion y Servicios SA's stock price today?
-
The ACS Actividades de Construccion y Servicios SA share price today is $9.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACSAY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACSAY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 62.78 | Buy |
Chaikin Money Flow: | 507 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.17 - 9.49) | Buy |
Bollinger Bands (100): | (8.32 - 9.24) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 74.74 | Buy |
Chaikin Money Flow: | 898979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (203.29 - 223.91) | Buy |
Bollinger Bands (100): | (221.8 - 277.54) | Buy |
ACSAY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.48 | Buy |
20-day SMA: | 9.35 | Buy |
50-day SMA: | 9.18 | Buy |
200-day SMA: | 8.38 | Buy |
8-day EMA: | 9.48 | Buy |
20-day EMA: | 9.39 | Buy |
50-day EMA: | 9.17 | Buy |
200-day EMA: | 8.41 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 216.22 | Buy |
20-day SMA: | 214.16 | Buy |
50-day SMA: | 227.04 | Buy |
200-day SMA: | 240.71 | Buy |
8-day EMA: | 223.2 | Buy |
20-day EMA: | 218.42 | Buy |
50-day EMA: | 226.38 | Buy |
200-day EMA: | 233.63 | Buy |
ACS Actividades de Construccion y Servicios SA Earnings Growth & ACSAY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.
ACS Actividades de Construccion y Servicios SA Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |